LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings
AUM
$11.3B
This Quarter Return
+2.31%
1 Year Return
+14.72%
3 Year Return
+73.17%
5 Year Return
+113.06%
10 Year Return
+348.26%
AUM
$5.5B
AUM Growth
+$5.5B
(+1.1%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
36.95%
Holding
821
New
51
Increased
90
Reduced
181
Closed
82
Top Buys
| 1 |
Fiserv
FI
|
$103M |
| 2 |
Becton Dickinson
BDX
|
$24.5M |
| 3 |
Amazon
AMZN
|
$17.3M |
| 4 |
Roper Technologies
ROP
|
$14.5M |
| 5 |
TE Connectivity
TEL
|
$11.9M |
Top Sells
| 1 |
TJX Companies
TJX
|
$11.1M |
| 2 |
Novo Nordisk
NVO
|
$10.9M |
| 3 |
Procter & Gamble
PG
|
$8.46M |
| 4 |
Johnson & Johnson
JNJ
|
$8.44M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.33M |
Sector Composition
| 1 | Technology | 27.8% |
| 2 | Healthcare | 17.78% |
| 3 | Financials | 10.19% |
| 4 | Consumer Staples | 9.56% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
ConocoPhillips
COP
$124B
| $3.55M | 0.06% |
59,788
-4,100
| -6% | -$243K |
|
102
Cintas
CTAS
$84.6B
| $3.38M | 0.06% |
19,802
-1,810
| -8% | -$309K |
|
103
Core Laboratories
CLB
$540M
| $3.37M | 0.06% |
31,136
-1,775
| -5% | -$192K |
|
104
Ovintiv
OVV
$10.8B
| $3.23M | 0.06% |
293,567
-2,900
| -1% | -$31.9K |
|
105
Walmart
WMT
$774B
| $3.22M | 0.06% |
36,167
+69
| +0.2% | +$6.14K |
|
|
MDP
106
DELISTED
Meredith Corporation
MDP
| $3.11M | 0.06% |
57,845
-46,918
| -45% | -$2.52M |
|
107
General Mills
GIS
$26.4B
| $3.09M | 0.06% |
68,670
-3,391
| -5% | -$153K |
|
108
Norfolk Southern
NSC
$62.8B
| $2.93M | 0.05% |
21,545
-625
| -3% | -$84.9K |
|
109
Boeing
BA
$177B
| $2.91M | 0.05% |
8,864
-100
| -1% | -$32.8K |
|
110
Wells Fargo
WFC
$263B
| $2.89M | 0.05% |
55,202
-560
| -1% | -$29.3K |
|
|
COL
111
DELISTED
Rockwell Collins
COL
| $2.87M | 0.05% |
21,315
-25
| -0.1% | -$3.37K |
|
112
Watsco
WSO
$16.3B
| $2.67M | 0.05% |
14,750
| – | – |
|
113
Enbridge
ENB
$105B
| $2.61M | 0.05% |
82,951
-47,380
| -36% | -$1.49M |
|
114
Chubb
CB
$110B
| $2.61M | 0.05% |
19,065
| – | – |
|
115
Brown-Forman Class B
BF.B
$14.2B
| $2.47M | 0.04% |
45,308
+9,420
| +26% | +$512K |
|
116
McCormick & Company Non-Voting
MKC
$18.9B
| $2.34M | 0.04% |
21,961
-30
| -0.1% | -$3.19K |
|
117
Biogen
BIIB
$19.4B
| $2.32M | 0.04% |
8,473
-50
| -0.6% | -$13.7K |
|
118
Pfizer
PFE
$141B
| $2.29M | 0.04% |
64,379
-6,251
| -9% | -$222K |
|
119
IBM
IBM
$227B
| $2.23M | 0.04% |
14,530
-1,017
| -7% | -$156K |
|
120
iShares MSCI EAFE ETF
EFA
$66B
| $2.22M | 0.04% |
31,804
+2,123
| +7% | +$148K |
|
121
Deere & Co
DE
$129B
| $2.21M | 0.04% |
14,252
+24
| +0.2% | +$3.73K |
|
122
Bristol-Myers Squibb
BMY
$96B
| $2.14M | 0.04% |
33,800
-875
| -3% | -$55.3K |
|
123
Broadridge
BR
$29.9B
| $2.1M | 0.04% |
19,156
-46
| -0.2% | -$5.05K |
|
|
RDS.A
124
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.05M | 0.04% |
32,145
| – | – |
|
125
Altria Group
MO
$113B
| $1.99M | 0.04% |
31,958
-780
| -2% | -$48.6K |
|